2020 American Transplant Congress
Liver Retransplantation (reLT) in the Modern Post-MELD, Post-DAA Era
School of Medicine, UCSF, San Francisco, CA
*Purpose: Liver retransplantation (reLT) is responsible for a small proportion of all liver transplants (LT), but outcomes are much worse than primary LT. Hepatitis C…2020 American Transplant Congress
Outcomes of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders: An Analysis of the UNOS/OPTN Database (1998 to 2019)
*Purpose: Post-transplant lymphoproliferative disease (PTLD) is a serious, potentially fatal complication after kidney transplantation. Existing literature on outcomes of kidney retransplantation in patients with prior…2020 American Transplant Congress
Impact of Donation after Circulatory Death Allografts on Outcomes Following Liver Re-Transplantation in the United States
*Purpose: Scarcity of donor organs in liver transplantation (LT) has necessitated consideration of donation after circulatory death (DCD) donors. Complications following LT and disease recurrence…2020 American Transplant Congress
Alemtuzumab and Associated Infectious and Transplant Outcomes in Renal Re-Transplant Patients
The Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC
*Purpose: The purpose of this study was to evaluate infectious and transplant outcomes exclusively in renal re-transplant patients who had received alemtuzumab for induction therapy.*Methods:…2020 American Transplant Congress
Recurrent Focal Segmental Glomerulosclerosis and the Possibility of Re-Transplantation
1Urology, UCLA, Los Angeles, CA, 2Nephrology, UCLA, Los Angeles, CA
*Purpose: Up to 30% of patients with focal segmental glomerulosclerosis (FSGS) experience recurrent disease after renal transplant, with high rates of progression to allograft failure…2020 American Transplant Congress
When CPRA Zero is Not the Hero: Does KAS Disadvantage Unsensitized Relisted Patients?
Medical University of South Carolina, Charleston, SC
*Purpose: Since the 2014 Kidney Allocation System (KAS) changes, patients with a very high calculated panel reactive antibody (CPRA) have received greater priority in deceased…2020 American Transplant Congress
Under-Diagnosed Hyperoxalosis in Transplant-Listed Patients
Nephrology, Johns Hopkins University, Baltimore, MD
*Purpose: In an era of increasing kidney transplantation (KTx), hyperoxalosis remains an under-recognized cause for allograft failure. Bariatric interventions are significant risk factors for oxalosis,…2020 American Transplant Congress
Differences in Immunosuppressive Therapy among Liver Retransplantation Recipients in a National Cohort
Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: There is no unified consensus as to the preferred immunosuppression (IS) strategy following liver retransplantation (reLT). This study explored: (i) factors associated with induction…2020 American Transplant Congress
Donor-Derived Cell-Free DNA May Not Discriminate Rejection in Kidney Transplant Recipients with a Prior Allograft in Place
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) is an injury biomarker discriminating rejection in kidney transplant (KTx) patients (pts). However, its performance when stratified by rejection risk…2020 American Transplant Congress
Re-Transplantation Outcomes in the United States Before and after DAA-Introduction
Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: The success of direct-acting antiviral (DAA) therapy has led to the widespread treatment of HCV and near-universal cure for chronically infected patients and improved…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 11
- Next Page »